Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

Welcome to the Moleculin Biotech First Quarter 2025 Update Conference ... trials and progress are considered preliminary and subject to change. Joining us on today's call from Moleculin’s ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

Moleculin Biotech expands its Annamycin trial for R ... to monitor preliminary efficacy and safety data at specified subject milestones. Disclaimer: This is an AI-generated summary of a press ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities ...

The tobacco rattle virus was engineered to express the RNA-guided TnpB enzyme ISYmu1 and guide RNA. This miniature CRISPR system enabled transgene-free germline genome editing in Arabidopsis ...

Subjects who had stable disease at the time ... and referencing the Moleculin Biotech Conference Call. The live audio webcast will be accessible on the Events page of the Investors section of ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

LBS Centre for Science and Technology; Palayam, Nandavanam, Thiruvananthapuram 695 033, has invited applications for the State Eligibility Test (SET), July ...